Iran (IMNA) - Mohammad Ghannadi claimed that Iran has achieved a very impressive position in the production of radiopharmaceuticals and that the nation also enjoys a good position in the export of diagnostic and therapeutic radiopharmaceuticals.
He stated that Iran has been successful in creating radiotherapeutic iodine-131 for the treatment of thyroid cancer.
Ghannadi noted that the company was successful in generating various radiopharmaceuticals to lessen bone pain in cancer patients who were in the latter stages of the disease, noting that at least one million Iranian patients utilize diagnostic radiopharmaceuticals like technetium-99 each year.
Earlier on Monday, Mohammad Eslami, the head of Iran's Atomic Energy Organization (AEOI), predicted that Iran will soon become a center for the manufacture of radiopharmaceuticals.
According to Mohammad Eslami, Iran has made progress over the last 16 months in a number of sectors, including the development of plasma technology and radiation technology in the domains of agriculture and medicine.
He said that Tehran is also able to export this vital item to other governments, claiming that the nation can now generate high-quality heavy water and has attained a good standing in the world in this respect.
Your Comment